Paper Details
- Home
- Paper Details
A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.
Author: BlueThomas R, FishmanMarc, GordonMichael S, O'GradyKevin E, SharmaBikash, TaxmanFaye, VocciFrank J
Original Abstract of the Article :
Buprenorphine can be effective in a variety of community substance use treatment settings outside of methadone programs, including outpatient programs and medical practices. In these settings, it has been found to be effective in reducing opioid use and retaining patients in treatment. Despite its e...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/30797042
データ提供:米国国立医学図書館(NLM)
Buprenorphine: A Promising Treatment for Opioid Use Disorder in Probation and Parole Settings
The study explores the potential of buprenorphine, a medication-assisted treatment, for individuals with opioid use disorder who are on probation or parole. The researchers investigated the effectiveness of buprenorphine in reducing opioid use and improving treatment retention in these individuals. The findings suggest that buprenorphine can be a valuable treatment option for individuals in this vulnerable population.
Expanding Access to Buprenorphine Treatment
The study highlights the need to expand access to buprenorphine treatment for individuals with opioid use disorder who are on probation or parole. This approach can offer a pathway to recovery and reduce recidivism rates. Just like a desert oasis providing water for weary travelers, buprenorphine can provide much-needed support and stability for individuals struggling with opioid addiction.
Addressing Barriers to Buprenorphine Treatment
The study underscores the importance of addressing barriers to buprenorphine treatment for individuals in probation and parole settings. These barriers may include limited access to qualified providers, stigma surrounding addiction treatment, and concerns about legal repercussions. Overcoming these challenges is crucial for maximizing the impact of buprenorphine treatment and improving outcomes for individuals with opioid use disorder.
Dr.Camel's Conclusion
The study emphasizes the need for a more comprehensive approach to addressing opioid use disorder, particularly in probation and parole settings. By expanding access to buprenorphine treatment and tackling existing barriers, we can create a more supportive environment for individuals seeking recovery. It's like building a network of oases in the desert, providing a lifeline for those struggling to find their way back to health and well-being.
Date :
- Date Completed 2020-06-16
- Date Revised 2023-10-06
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.